Procter & Gamble Company (The) $PG Stock Position Lowered by Glenview Trust Co

Glenview Trust Co cut its holdings in shares of Procter & Gamble Company (The) (NYSE:PG) by 5.5% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 342,398 shares of the company’s stock after selling 19,948 shares during the quarter. Glenview Trust Co’s holdings in Procter & Gamble were worth $49,744,000 at the end of the most recent reporting period.

Several other large investors also recently added to or reduced their stakes in the stock. BlackRock Inc. acquired a new position in Procter & Gamble in the 2nd quarter valued at about $27,862,105,000. State Street Corp raised its stake in shares of Procter & Gamble by 1.0% in the 2nd quarter. State Street Corp now owns 102,216,308 shares of the company’s stock valued at $14,988,999,000 after acquiring an additional 965,461 shares during the period. Bank of America Corp DE purchased a new stake in shares of Procter & Gamble in the 2nd quarter valued at approximately $3,850,628,000. Bank of New York Mellon Corp acquired a new position in shares of Procter & Gamble in the 2nd quarter worth approximately $2,281,505,000. Finally, Dimensional Fund Advisors LP lifted its holdings in shares of Procter & Gamble by 2.6% in the 1st quarter. Dimensional Fund Advisors LP now owns 11,797,916 shares of the company’s stock worth $1,704,182,000 after acquiring an additional 300,280 shares during the last quarter. 65.77% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of research firms recently weighed in on PG. Barclays increased their price objective on shares of Procter & Gamble from $152.00 to $165.00 and gave the stock an “equal weight” rating in a research report on Monday. Bank of America cut their target price on Procter & Gamble from $170.00 to $166.00 and set a “buy” rating on the stock in a research report on Friday, July 10th. Evercore upgraded Procter & Gamble from an “in-line” rating to an “outperform” rating and set a $166.00 price target on the stock in a research note on Tuesday, October 6th. BNP Paribas Exane raised their price target on Procter & Gamble from $177.00 to $189.00 and gave the stock an “outperform” rating in a research report on Friday, October 23rd. Finally, JPMorgan Chase & Co. lifted their price objective on Procter & Gamble from $162.00 to $180.00 and gave the company an “overweight” rating in a research note on Friday, October 23rd. Fifteen investment analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the company’s stock. According to data from MarketBeat, Procter & Gamble currently has an average rating of “Moderate Buy” and an average target price of $170.57.

Key Headlines Impacting Procter & Gamble

Here are the key news stories impacting Procter & Gamble this week:

• Positive Sentiment: Analyst upgrade: Freedom Broker upgraded PG from “hold” to “buy,” providing a positive signal for the stock and reflecting greater confidence in the company’s outlook. Freedom Broker upgrades Procter & Gamble to buy from hold
• Positive Sentiment: Dividend appeal remains strong: Articles highlighted PG as a long-standing dividend leader, supporting its appeal to income-focused and defensive investors. The company’s record of dividend increases may help underpin demand for the shares, particularly when investors favor stable consumer-staples businesses. Dividend Kings article Trusted dividend stocks article
• Neutral Sentiment: Bond issuance adds balance-sheet context: PG’s euro- and dollar-denominated bond sale provides liquidity and funding flexibility, but it also draws attention to leverage, interest costs, and the company’s relatively elevated valuation. Procter & Gamble bond sale
• Neutral Sentiment: Growth story under review: Commentary on PG points to accelerating revenue growth, while also noting that higher operating costs could pressure margins and earnings. Investors are weighing improved sales momentum against cost inflation. Procter & Gamble revenue growth and costs What changed in Procter & Gamble’s story
• Negative Sentiment: Mixed rating signals and valuation risk: DZ Bank downgraded PG from “strong-buy” to “hold.” With shares trading at a premium valuation, a more cautious analyst stance could weigh on upside unless earnings growth accelerates. DZ Bank rating change
• Negative Sentiment: Advertising challenge produced only a limited win: Following PG’s challenge, the National Advertising Division supported Carpe’s $19.95 reference price but recommended changes or removal of other savings, free-shipping, comparative-performance, and “first” 100-hour protection claims. The outcome may modestly strengthen competitive advertising standards, but it does not represent a material financial catalyst for PG. National Advertising Division decision involving Carpe

Insider Buying and Selling at Procter & Gamble

In related news, CFO Andre Schulten sold 3,914 shares of the company’s stock in a transaction that occurred on Monday, October 5th. The shares were sold at an average price of $145.34, for a total transaction of $568,860.76. Following the sale, the chief financial officer directly owned 65,618 shares in the company, valued at approximately $9,536,920.12. This represents a 5.63% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CEO Shailesh Jejurikar sold 35,000 shares of the firm’s stock in a transaction that occurred on Friday, October 23rd. The shares were sold at an average price of $163.09, for a total transaction of $5,708,150.00. Following the completion of the sale, the chief executive officer directly owned 55,391 shares in the company, valued at approximately $9,033,718.19. This trade represents a 38.72% decrease in their position. The SEC filing for this sale provides additional information. In the last 90 days, insiders sold 58,647 shares of company stock valued at $9,268,508. 0.23% of the stock is currently owned by company insiders.

Procter & Gamble Stock Up 0.5%

Shares of NYSE:PG opened at $161.42 on Friday. The firm has a market capitalization of $374.14 billion, a PE ratio of 24.31, a price-to-earnings-growth ratio of 3.95 and a beta of 0.39. Procter & Gamble Company has a 1 year low of $137.62 and a 1 year high of $167.25. The company has a debt-to-equity ratio of 0.40, a current ratio of 0.72 and a quick ratio of 0.53. The firm’s 50-day moving average is $149.99 and its two-hundred day moving average is $148.94.

Procter & Gamble (NYSE:PG) last posted its quarterly earnings data on Thursday, October 22nd. The company reported $2.00 EPS for the quarter, beating the consensus estimate of $1.89 by $0.11. The business had revenue of $23.28 billion during the quarter, compared to analyst estimates of $22.80 billion. Procter & Gamble had a net margin of 18.23% and a return on equity of 31.02%. The business’s revenue for the quarter was up 4.0% compared to the same quarter last year. During the same quarter last year, the firm posted $1.99 earnings per share. Analysts predict that Procter & Gamble Company will post 6.99 EPS for the current year.

Procter & Gamble Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, November 16th. Stockholders of record on Friday, October 23rd will be given a dividend of $1.0885 per share. The ex-dividend date of this dividend is Friday, October 23rd. This represents a $4.35 dividend on an annualized basis and a dividend yield of 2.7%. Procter & Gamble’s payout ratio is currently 65.51%.

About Procter & Gamble

Procter & Gamble Company (NYSE: PG) is a global consumer products company that develops, manufactures and markets branded products used in households and personal care. Its portfolio includes personal health and grooming products, beauty and skin care items, baby, feminine and family care products, fabric and home care products, and oral care products.

The company’s well-known brands include Pampers, Tide, Gillette, Crest, Oral-B, Head & Shoulders, Pantene, Olay, Old Spice, Dawn, Febreze and Mr.